Prognostic Significance of Amino Acid and Biogenic Amines Profiling in Chronic Kidney Disease. Biomedicines. 2023 Oct 13;11(10):2775. doi: 10.3390/biomedicines11102775. PMID: 37893147; PMCID: PMC10604890.F.I.: 4,72 Q1
Prognostic value of haematological parameters and [18F]FDG PET/CT metabolic parameters in head and neck cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023 Oct 18:S2253-8089(23)00081-2. doi: 10.1016/j.remnie.2023.10.002. Epub ahead of print. PMID: 37863392.
Approach to obesity in the elderly population: a consensus report from the Diabetes, Obesity and Nutrition Working Group of SEMI (Spanish Society of Internal Medicine). Rev Clin Esp (Barc). 2023 Oct;223(8):493-498. doi: 10.1016/j.rceng.2023.07.005. Epub 2023 Jul 17. PMID: 37468094. F.I.: 1,3 Q3
Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure. Rev Clin Esp (Barc). 2023 Oct;223(8):499-509. doi: 10.1016/j.rceng.2023.07.008. Epub 2023 Jul 26. PMID: 37507048. F.I.: 1,3 Q3
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry. Sci Rep. 2023 Oct 18;13(1):17731. doi: 10.1038/s41598-023-42735-5. PMID: 37853011; PMCID: PMC10584827. F.I.: 4,38 Q1
Glycemic control and prescription profiles in internal medicine inpatients: The role of frailty. Eur J Intern Med. 2023 Oct 21:S0953-6205(23)00377-1. doi: 10.1016/j.ejim.2023.10.022. Epub ahead of print. PMID: 37872036. F.I.: 4,49 Q1
Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey. Immunol Res. 2023 Oct;71(5):749-759. doi: 10.1007/s12026-023-09389-x. Epub 2023 May 17. PMID: 37195550. F.I.: 2,83 Q3
Vaginal wall thickness as potential biomarker of vaginal health. A proposal for standardized ultrasound measurement using three-dimensional transvaginal ultrasound. J Clin Ultrasound. 2023 Oct;51(8):1366-1369. doi: 10.1002/jcu.23547. Epub 2023 Aug 30. PMID: 37646482. F.I.: 0,91 Q4
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study. Actas Dermosifiliogr. 2023 Oct 25:S0001-7310(23)00847-5. English, Spanish. doi: 10.1016/j.ad.2023.10.016. Epub ahead of print. PMID: 37890617. F.I.: 0,73 Q3
A new technique in the treatment of intestinal malrotation. Cir Pediatr. 2023 Oct 1;36(4):191-194. English, Spanish. doi: 10.54847/cp.2023.04.16. PMID: 37818902. F.I.: 0,22 Q4